We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Addresses Postmarket Study Processes
FDA Guidance Addresses Postmarket Study Processes
February 22, 2006
The FDA intends to conduct timely reviews of drugmakers' postmarketing commitment protocols, according to a new guidance on streamlining postmarket reporting procedures.